Frédéric Bigot
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Diagnosis and Treatment
-
- Lung Cancer Treatments and Mutations
- Renal cell carcinoma treatment
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 23
- Cancer Immunotherapy and Biomarkers 8
- COVID-19 and healthcare impacts 6
- Cancer Diagnosis and Treatment 5
- PARP inhibition in cancer therapy 3
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Christophe Massard (5 shared papers)Alberto Carmona‐Bayonas (2 shared papers)Aurélien Marabelle (3 shared papers)Sophie C. Postel-Vinay (3 shared papers)Vincent Ribrag (2 shared papers)Anas Gazzah (2 shared papers)Jean‐Charles Soria (3 shared papers)Jean‐Marie Michot (3 shared papers)
In The Last Decade
Frédéric Bigot
39 papers receiving 520 citations
Peers
Comparison fields: 5 of 49
- Oncology 236
- Pulmonary and Respiratory Medicine 145
- Cancer Research 33
- Hepatology 13
- Surgery 60
Countries citing papers authored by Frédéric Bigot
This map shows the geographic impact of Frédéric Bigot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Bigot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Bigot more than expected).
Fields of papers citing papers by Frédéric Bigot
This network shows the impact of papers produced by Frédéric Bigot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Bigot. The network helps show where Frédéric Bigot may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Bigot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 174 | |
| 2 | 2011 | 51 | |
| 3 | 2013 | 49 | |
| 4 | 2022 | 46 | |
| 5 | 2024 | 37 | |
| 6 | 2016 | 21 | |
| 7 | 2009 | 16 | |
| 8 | 2023 | 12 | |
| 9 | 2025 | 12 | |
| 10 | 2018 | 11 | |
| 11 | 2017 | 10 | |
| 12 | 2021 | 10 | |
| 13 | 2023 | 10 | |
| 14 | 2024 | 9 | |
| 15 | 2020 | 8 | |
| 16 | 2021 | 6 | |
| 17 | 2025 | 6 | |
| 18 | 2024 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2017 | 3 |
About Frédéric Bigot
Frédéric Bigot is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology, Infectious Diseases and Cancer Research, having authored 46 papers that have together received 535 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), COVID-19 and healthcare impacts (6 papers), Cancer Diagnosis and Treatment (5 papers), Endometrial and Cervical Cancer Treatments (3 papers), PARP inhibition in cancer therapy (3 papers) and Cervical Cancer and HPV Research (2 papers). The work is most often cited by research in Oncology (236 citations), Pulmonary and Respiratory Medicine (145 citations), Cancer Research (33 citations), Hepatology (13 citations) and Surgery (60 citations). Frédéric Bigot has collaborated with scholars based in France, Spain and Italy. Frequent co-authors include Christophe Massard, Alberto Carmona‐Bayonas, Aurélien Marabelle, Sophie C. Postel-Vinay, Vincent Ribrag, Anas Gazzah, Jean‐Charles Soria, Jean‐Marie Michot, Jessica Menis and Capucine Baldini. Their work appears in journals such as Annals of Oncology, ESMO Open, Cancers, Investigational New Drugs and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.